Examining health-related quality of life in men treated for prostate cancer

World Journal of Urology

Volumn 17, Issue 4, 1999, Pages 205-210

  Litwin, Mark S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; HEALTH SURVEY; HUMAN; MALE; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RESEARCH; REVIEW;

COHORT STUDIES; HEALTH STATUS INDICATORS; HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH;

EID: 0033174490     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450050134     Document Type: Article

References (58)

1. Patrick DL, Erickson P (1993) Assessing health-related quality of life for clinical decision-making: Kluwer. Dordrecht
2. WHO (1948) Constitution of the World Health Organization, basic documents. WHO. Geneva
3. Litwin MS (1994) Measuring health related quality of life in men with prostate cancer. J Urol 152: 1882-1887
4. Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27 [Suppl 3]: S217-S232
5. Tulsky DS (1990) An introduction to test theory. Oncology (Hunting!) 4: 438
6. Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16: 297-334
7. Nunnally JC (1978) Psychometric theory. 2nd edn. McGrawHill, New York
8. Tannock IF (1990) Management of breast and prostate cancer: how does quality of life enter the equation? Oncology (Huntingt)4: 149-156
9. Litwin MS, Lübeck DP, Henning JM, Carroll PR (1998) Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol 159: 1988-1992
10. Gill TM. Feinstein AR (1994) A critical appraisal of the quality of quality of life measurements. JAMA 272: 619-626
11. Karnofsky DA, Buchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CMM (ed) Evaluation of chemotherapeutic agents. Columbia University. New York
12. Osoba D (1997) Measuring the effect of cancer on quality of life. CRC, Boca Raton
13. Stewart AL, Hays RD, Ware JE Jr (1988) The MOS shortform general health survey. Reliability and validity in a patient population. Med Care 26: 724-735
14. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483
15. Stewart AL, Greenfield S, Hays RD, Wells K. Rogers WH, Berry SD. et al (1989) Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 262: 907-913
16. McDowell I. Ewell C (1987) Measuring health: a guide to rating scales and questionnaires. Oxford University, New York
17. Kaplan RM, Bush JW. Berry CC (1976) Health status: types of validity and the index of well-being. Health Serv Res 11: 478507
18. Kaplan RM. Bush JW (1982) Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1: 61-80
19. Kaplan RM. Anderson JP (1988) A general health policy model: update and applications. Health Serv Res 23: 203-235
20. Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS (1976) The sickness impact profile: validation of a health status measure. Med Care 14: 57-67
21. Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The Sickness Impact Profile: development and final revision of a health status measure. Med Care 19: 787-805
22. Pollard WE. Bobbitt RA. Bergner M. Martin DP, Gilson BS (1976) The Sickness Impact Profile: reliability of a health status measure. Med Care 14: 146-155
23. Hunt SM, McEwen J, McKenna SP (1985) Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 35: 185-188
24. Martini CJ, McDowell I (1976) Health status: patient and physician judgments. Health Serv Res 11: 508-515
25. Tarlov AR. Ware JE Jr, Greenfield S, Nelson EC. Perrin E. Zubkoff M (1989) The Medical Outcomes Study. An application of methods for monitorina the results of medical care. JAMA 262: 925-930
26. Aaronson NK, Ahmedzai S, Bergman B. Bullinger M, Cull A, Duez NJ, et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376
27. Ganz PA. Schag CA. Lee JJ, Sim MS (1992) The CARES: a generic measure of health-related quality of life for patients with cancer. Quality Life Res I: 19 29
28. Sehag CAC. Heinrich RL (I9SS) Cancer Rehabilitation Evaluation System (CARES) manual. CARES Consultants. Los Angeles
29. Schag CA. Heinrich RE (1990) Development of a comprehensive quality of life measurement tool: CARES. Oncology (Hunting!) 4: 135 138
30. Schag CA. Ganz PA. Heinrich RL (1991) Cancer Rehabilitation Evaluation System short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer 68: 1406-1413
31. Cella DF. Tulsky DS. Gray G. Sarafian B. Linn E. Bonomi A, et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11: 570 579
32. Schipper H. Clinch J. McMurray A. Levilt M (1984) Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 2: 472-483
33. Finkelstein DM, Cassileth BR. Bonomi PD. Ruckdeschel JC. Ezdinli EZ, Wolter JM (1998) A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 11: 630 633
34. Litwin MS. Hays RD, Fink A. Ganz PA. Leake B. Brook RH (1988) The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 36: 1002-1012
35. Krongrad A, Perczek RE. Burke MA. Granville LJ, Lai H, Lai S (1997) Reliability of Spanish translations of select urological quality of life instruments. J Urol 158: 493-496
36. Esper P, Mo F. Chodak G, Sinner M, Cella D, Pienta KJ (1997) Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50: 920-928
37. Shrader-Bogen CL, Kjellberg JL, McPherson CP. Murray CL (1997) Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 79: 1977-1986
38. Borghede G, Sullivan M (1996) Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Quality Life Res 5: 212-222
39. Borghede G, Karlsson J, Sullivan M (1997) Quality of life in patients with prostatic cancer: results from a Swedish population study. J Urol 158: 1477-1485 [discussion 1486]
40. Albertsen PC. Aaronson NK. Muller MJ, Keller SD, Ware JE Jr (1997) Health-related quality of life among patients with metastatic prostate cancer. Urology 49: 207-216
41. L Cassileth BR, Soloway MS, Vogelzang NJ, Schellhammer PS, Seidmon EJ, Hail HI, et al (1989) Patients' choice of treatment in stage D prostate cancer. Urology 33 [Suppl 5]: 57-62
42. Cassileth BR, Soloway MS, Vogelzang NJ. Chou JM, Schellhammer PD, Seidmon EJ, et al (1992) Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group. Quality Life Res 1: 323 329
43. Herr HW, Kornblith AB, Ofman U (1993) A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 71 [Suppl 3]: 1143-1150
44. Litwin MS, Shpall AI. Dorey F. Nguyen TH (1998) Quality-oflife outcomes in long-term survivors of advanced prostate cancer. Am J Clin Oncol 21: 327 332
45. Suva FC da. Fossa SD. Aaronson NK, Serbouti S, Denis L. Casselman J. el al (1996) The quality of life of patients with newly diagnosed Ml prostate cancer: experience with EORTC clinical trial 30853. Eur J Cancer 32A: 72 77
46. Tannock I. Gospodarowic/ M. Meakin W. Panzarella T. Stewart L. Rider W (1989) Treatment of metastatic proslatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 7: 590 597
47. Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1: 277 299
48. Kornblith AB, Herr HW. Ofman US. Scher HI. Holland .1C (1994) Quality of life of patients with prostate cancer and their spouses: the value of a data base in clinical care. Cancer 73: 2791 2802
49. Fossa SD, Aaronson NK, Nevvling D, Cangh PJ van. Denis L. Kurth KH. et al (1990) Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group. Eur J Cancer 26: 1133 1136
50. Pedersen KV, Carlsson P, Rahmquist M, Varenhorst E (1993) Quality of life after radical retropubic prostatectomy for carcinoma of the prostate. Eur Urol 24: 7 11
51. Litwin MS. Hays RD, Fink A, Ganz PA. Leake B, Leach GE, et al (1995) Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273: 129-135
52. Fowler FJ Jr, Barry MJ. Lu-Yao G, Wasson J, Roman A. Wennberg J (1995) Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 45: 1007 1013 [discussion 1013 1015]
53. Lim AJ, Brandon AH. Fiedler J, Brickman AL. Boyer CI, Raub WA Jr, et al (1995) Quality of life: radical prostatectomy versus radiation therapy for prostate cancer [see comments]. J Urol 154: 1420-1425
54. Fowler FJ Jr. Barry MJ, Lu-Yao G. Wasson JH. Bin L (1996) Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 14: 22582265
55. Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, et al (1998) Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol 16: 275-283
56. Lübeck DP. Litwin MS, Henning JM, Stier DM. Mazonson P. Fisk R. et al (1996) The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologie Research Endeavor. Urology 48: 773-117
57. Lübeck DP, Litwin MS. Henning JM. Carroll PR (1997) Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Quality Life Res 6: 385-392
58. Penson DF. Litwin MS, Lübeck DP, Flanders S, Pasta DJ, Carroll PR (1998) Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prostate Cancer Prostatic Dis 1: 134-143